Hjem › Juvenil artritt › District of Columbia
Kliniske studier for Juvenil artritt i District of Columbia
4 studier for Juvenil artritt søker deltakere på steder i District of Columbia.
Byer i District of Columbia
Offisiell studietekst (engelsk)
Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.
- Childrens National Medical Center /ID# 253344, Washington D.C.
RekruttererFase 3
Alder 1 til 17 · Alle kjønn · Oppdatert 15. sep. 2026 · NCT05609630A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
- Childrens National Medical Center /ID# 259284, Washington D.C.
RekruttererFase 3
Alder 5 til 17 · Alle kjønn · Oppdatert 1. sep. 2026 · NCT06100744Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
- Childrens National Medical Center, Washington D.C.
RekruttererObservasjonsstudie
Opp til 21 år · Alle kjønn · Oppdatert 27. aug. 2026 · NCT02418442Development of a Therapeutic Endpoint in Pediatric Rheumatologic Conditions
- Children's National Health System, Washington D.C.
RekruttererObservasjonsstudie
Alder 5 til 21 · Alle kjønn · Oppdatert 24. jul. 2026 · NCT04833465Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.